All are true about pancreatic fistula in chronic pancreatitis except
Trials have demonstrated the benifit of prophylactic octreotide in the prevention of pancreatic fistula; however the role of octreotide, once fistula is established remains unclear. In such situations, the octreotide administration is continued for upto 2 weeks, while in those who donot seem to respond, it is discontinued Ref: Blumga 5th edition Pgno :965
Most cases resolve spontaneously by Conservative treatment
Somatostatin is effective in fistula closure
In prevention of fistula, adherence to standardised and meticulous technique is more impoant than the pancreatic texture or the type of anastomosis used
Early intervention is required if associated with hemorrhage or sepsis
G.I.T